BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15761235)

  • 1. Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.
    Gibney J; Johannsson G
    Horm Res; 2004; 62 Suppl 1():66-72. PubMed ID: 15761235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
    Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB
    Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids.
    Jørgensen JO; Christensen JJ; Krag M; Fisker S; Ovesen P; Christiansen JS
    Horm Res; 2004; 62 Suppl 1():73-6. PubMed ID: 15761236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency.
    Aimaretti G; Corneli G; Rovere S; Granata R; Baldelli R; Grottoli S; Ghigo E
    Horm Res; 2004; 62 Suppl 1():26-33. PubMed ID: 15761229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
    Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
    Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I; Hizuka N; Itoh E; Yasumoto K; Ishikawa Y; Murakami Y; Sata A; Takano K
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly induced by growth hormone replacement therapy.
    Karges B; Pfäffle R; Boehm BO; Karges W
    Horm Res; 2004; 61(4):165-9. PubMed ID: 14707471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults.
    Cook DM; Biller BM; Vance ML; Hoffman AR; Phillips LS; Ford KM; Benziger DP; Illeperuma A; Blethen SL; Attie KM; Dao LN; Reimann JD; Fielder PJ
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4508-14. PubMed ID: 12364427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I levels in healthy children.
    Clayton PE; Hall CM
    Horm Res; 2004; 62 Suppl 1():2-7. PubMed ID: 15761226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.